9SA-30978-92662
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 052 / VT
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-15
- 2021-01-16
- 2021-01-29
-
2021-02-01
Dose 2 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-10
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-17
-
2022-02-03
Survey response — 12 months, dose 2MedDRA: Kidney infection, Urinary tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: UTI/ kidney infectionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-01 | Pfizer-BioNTech |
Free text
Release 11 — 12 months, dose 2
Symptoms: UTI/ kidney infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Kidney infection | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release